ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
CordenPharma, a German contract development and manufacturing organization, has completed a 3,000 L expansion of its solid-phase peptide plant in Boulder, Colorado, bringing capacity at the site to 13,000 L. The new capacity allows the firm to manufacture 400 kg of a complex, long peptide per single batch, according to Matthieu Giraud, the firm’s director of peptide, lipid, and carbohydrate operations. The site also features a 100 cm high-pressure reverse-phase purification column.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X